DBGI (DBGI) Stock Price & Analysis
DBGI (DBGI) rose 0.13% to USD 3.78 as of September 8, 2026 at 16:37 UTC, according to Nexqual real-time market data.
DBGI last closed at USD 3.78; the session ranged USD 3.62–3.89 on volume of 71,074 shares. Market capitalization is —, with a 52-week range of USD 3.14–720 (NCM). Source: Nexqual, September 8, 2026 at 16:37 UTC.
Key Statistics (as of September 8, 2026 at 16:37 UTC)
| Price | USD 3.78 |
|---|---|
| Change | ▲ 0.13% (up) |
| Previous Close | USD 3.78 |
| Open | USD 3.78 |
| Day Range | USD 3.62 – 3.89 |
| 52-Week Range | USD 3.14 – 720 |
| Volume | 71,074 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (DBGI)
Nexqual's technical model rates DBGI "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 16:37 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 27.3 (oversold) |
| vs SMA50 | Below (USD 17.14) |
| MACD | -3.9 (negative) |
From DBGI's Latest SEC 10-K Filing (filed 2026-04-15)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ENSC | Ensysce Biosciences, Inc. | USD 0.46 | ▲ 3.98% |
| GROM | Grom Social Enterprises, Inc. | USD 0 | ▲ 0% |
| AUUD | Auddia Inc. | USD 1 | ▼ 0.1% |
| PALI | Palisade Bio, Inc. | USD 2.18 | ▲ 6.1% |
| KAVL | Kaival Brands Innovations Group | USD 0.03 | ▲ 9.13% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 16:37 UTC. This page is informational and not investment advice.